NKTR News

Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm

NKTR Shareholder Alert: Nektar Therapeutics Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Pursues Shareholder Class Action Against Nektar Therapeutics – NKTR

Robbins LLP Encourages NKTR Stockholders to Contact The Firm For Information About The Class Action Against Nektar Therapeutics

Robbins LLP Encourages NKTR Stockholders to Contact The Firm For Information About The Class Action Against Nektar Therapeutics

Robbins LLP Encourages NKTR Stockholders to Contact The Firm For Information About The Class Action Against Nektar Therapeutics

ROSEN, A HIGHLY RANKED NATIONAL FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

DEADLINE ALERT for BSX, EOSE, SLNO, and NKTR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm